Bird & Bird
In major recent developments, a confidentiality request was rejected, Samsung and its representative A&O Shearman secured a partial win, and EIP made a new hire
Partners at Bird & Bird and Taylor Wessing discuss how Saudi Arabia offers unique opportunities for firms dealing in IP and tech
IP leaders at Brandsmiths and Bird & Bird, who were on opposing sides at the UK Supreme Court in Iconix v Dream Pairs, unpick the landmark case and its ramifications
In Iconix v Dream Pairs, the Supreme Court said the Court of Appeal was wrong to interfere with an earlier ruling, prompting questions about the appeal court’s remit
Sponsored
Sponsored
-
Sponsored by Bird & BirdSeiko Hidaka of Bird & Bird and Kento Sumi, currently seconded to Bird & Bird, analyse a landmark decision in a standard-essential patent case and its implications for licensing practices and future litigation in Japan -
Sponsored by Bird & BirdWendela Hårdemark and Beatrice Rälg of Bird & Bird explore the outlook for Swedish copyright law, as reciprocity rules are set to be dismantled, and contract interpretation takes a decisive new direction
-
Sponsored by Bird & BirdLiz McAuliffe of Bird & Bird says Intel’s triumph against R2 Semiconductor in the High Court of England and Wales had a limited impact on parallel litigation in other jurisdictions before a high-stakes settlement
-
Sponsored by Bird & BirdMarijn van der Wal of Bird & Bird says a landmark Unified Patent Court case highlights the potential of expert witnesses to enhance patent litigation and shape procedural practices in Europe
-
Sponsored by Bird & BirdKatharina Pehle of Bird & Bird considers the legislative progress and potential impact of a regulation on standard-essential patents as the proposal continues to draw criticism, despite approval by the European Parliament
-
Sponsored by Bird & BirdEmilia Zalewska and Andrzej Stelmachowski of Bird & Bird provide insights into two matters considered by the Unified Patent Court and a Polish court concerning the imminent infringement of patent rights in the pharmaceutical industry
